OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
January 01, 2023
Efforts to optimize the ideal blend of technology and best practices that are needed to protect and deliver time- and temperature-sensitive biologic therapies, vaccines, and cell and gene therapies continue to evolve.
December 14, 2022
Thermo Fisher Scientific’s new facility in Hangzhou, China, is designed to boost biologics and sterile development and manufacturing capabilities in the Asia-Pacific region.
December 01, 2022
Digitalization of bioprocessing is slowly bringing benefits to the biopharma industry.
November 28, 2022
High-cost-per-dose large molecules can make a big impact on cell and gene therapy supply chain management.
November 08, 2022
Scorpion’s new facility is designed for the development and manufacturing of clinical and commercial-scale biologic drugs.
October 12, 2022
CBER maps modernization plan to handle surge in research and applications.
August 02, 2022
Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.
July 27, 2022
WuXi STA is opening a new large-scale oligonucleotide and peptide manufacturing facility.
June 29, 2022
MilliporeSigma and Lotte Group will collaborate on facility design and workforce training for a new biologics business unit in the US.
June 10, 2022
Astellas Pharma has opened its new gene therapy manufacturing facility in Sanford, NC, which will support clinical- and commercial-scale manufacturing of AAV vectors for gene therapies.